NCT01392768View on ClinicalTrials.gov

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization

PHASE3CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
EpilepsyPartial Seizures
Interventions
DRUG

Levetiracetam

Oral solution (Each mL contains 100mg of levetiracetam) or immediate-release tablets (Tablets containing 500mg or 1000mg of levetiracetam)

DRUG

Placebo

Placebo, properly standardized to suit the characteristics of each dosage form (oral solution and tablets) of levetiracetam

Sponsors
All Listed Sponsors
lead

Ache Laboratorios Farmaceuticos S.A.

INDUSTRY